Enhancing Clinical Outcomes & Success Rates: Optimizing Bacteriophage Drug Development Platforms
Time: 9:05 am
day: Pre-Conference Workshop Day
Details:
With heightened momentum in bacteriophage therapy, the industry is anticipating substantial updates in clinical results, which will be the defining moment for facing antimicrobial resistance. However, this is easier said than done, given the complexity of clinical trial design, regulatory requirements, and patient recruitment. We will utilize this interactive workshop to give you hands-on guidance on designing and preparing a platform to develop an efficacious phage drug that supports pipeline progression and enhance clinical outcomes.
Join this 1-hour session and learn how to:
- Integrate technologies and strategies to identify phage for better selection of phage cocktails
- Combine in vitro, in vivo, and eIND data to facilitate clinical translatability for pipeline development
- Construct ‘artificial patient’ models in lab to discover rare phage for improved patient outcomes
